Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması
Proje Grubu: TBAG Sayfa Sayısı: 47 Proje No: 107T179 Proje Bitiş Tarihi: 01.01.2009 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması
Öz: -
Anahtar Kelime: Konular:
Erişim Türü: Erişime Açık
- ALLEN M.T., Cullis P.R., Drug Delivery System Entering the Main Stream, Science, 303 (5665), 1818 – 1822, (2004).
- BAT, E., Synthesis and Characterization of Hyperbranched and Air Drying Fatty Acid Based Resins, (Phd Thesis), Middle East Technical University, (2005).
- BHARATHI P., Moore J.S., Controlled Synthesis of Hyperbranched Polymers by Slow Monomer Addition to Core, Macromolecules, 33, 3212-3218, (2000).
- BIOLOGICAL INDUSTRIES,. Cell Proliferation Assay with XTT Reagent Protocol, (2002).
- CHAWLA J.S., Amiji M.M., Biodegradable Poly(ε-caprolactone) Nanoparticles for Tumor Targeted Delivery of Tamoxifen, International Journal of Pharmaceutics, 249, 127-138, (2002).
- CHENG K-C., Effect on Feed Rate on Structure of Hyperbranched Polymers Formed by Stepwise Addition of AB2 Monomers into Functional Cores, Polymer, 44, 1259-1266, (2003).
- CHU H., Liu N., Wang X., Jiao Z., Chen Z., Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC–b–PBMA copolymer, International Journal of Pharmaceutics, Article in press, (2009).
- COLEY H. M., Mechanisms and Strategies to overcome chemotherapy resistance in metastatic breast cancer, Cancer Treatment Reviews, 34, 378-390, (2008)
- DONG Y., Feng S.S., Methoxy Poly(ethylene glycol) Poly(lactide) (MPEG-PLA) Nanoparticles for Controlled Delivery of Anticancer Drugs, Biomaterials, 25, 2843– 2849, (2004).
- FASSAS A. B., Bolanos A.P., Shanholtz C., Cottler M., Tricot G., Tamoxifen-based Treatment Induces Clinically Meaningful Responses in Multiple Myeloma Patients with Relapsing Disease After Autotransplantation, Leukemia&Lymphoma, 42, 1323– 1328, (2001).
- FRECHET J.M.J., Dendrimers and Other Dendritic Macromolecules: From Building Blocks to Functional Assemblies in Nanoscience and Nanotechnology, Journal of Polymer Science: Part A : Polymer Chemistry, 41, 3713–3725, (2003).
- GILLIES E.R., Fréchet J.M.J., Dendrimers and Dendritic Polymers in Drug Delivery, Drug Discovery Today, 10, 35-43, (2005).
- HECKER R., Fawell P.D., Jefferson A., The Agglomeration of High Molecular Mass Polyacrylamide in Aqueous Solutions, Journal of Applied Polymer Science, 70, 2241- 2250, (1998).
- JAIN J.P., Modi S., Kumar N., Hydroxy Fatty Acid Based Polyanhydride as Drug Delivery System: Synthesis, Characterization, In Vitro Degradation, Drug Release, and Biocompatibility, Journal of Biomedical Materials Research, 84(3), 740-752, (2008).
- JESSANI N., Humphrey M., McDonald W. H., Niessen S., Masuda K., Gangadharan B., Yates J. R., Mueller B. M., Cravatt B. F., Carcinoma and Stromal Enzyme Activity Profiles Associated with Breast Tumor Growth In Vivo, Proceedings of National Academy of Sciences, 101(38), 13756-13761, (2004).
- JESUS P. L. O., Ihre R. H., Gagne H., Frechet J. M. J., Polyester Dendritic Systems for Drug Delivery Applications: In vitro and In vivo Evaluation, Bioconjugate Chemstry, 13, 453-461, (2002).
- KLAJNERT B., Bryszewska M., Dendrimers: Properties and Applications, Acta Biochimica Polonica, 48, 199-208, (2000).
- LONG B.J., Jelovac D., Handratta V., Thiantanawat A., MacPherson N., Ragaz J., Goloubeva O.G., Brodie A.M., Therapeutic Strategies Using the Aromatase Inhibitor Letrozole and Tamoxifen in a Breast Cancer Model, Journal of the National Cancer Institute, 96,456-65, (2004).
- MAILLARD S., Ameller T., Gauduchon J., Gougelet A., Gouilleux F., Legrand P., Marsaud V., Fattal E., Sola B., Renoir J.M., Innovative Drug Delivery Nanosystems Improve The Anti-Tumor Activity In Vitro and In Vivo of Anti-Estrogens in Human Breast Cancer and Multiple Myeloma, Journal of Steroid Biochemistry & Molecular Biology, 94, 111–121, (2005).
- MIAO Z.M., Cheng S.X., Zhang X.Z., Zhuo R.X., Synthesis, Characterization and Degradation Behavior of Amphiphilic Poly-α,β-[N-(2-hydroxyethyl)-L-aspartamide]-gpoly(ε-caprolactone), Biomacromolecules, 6, 3449-3457, (2005).
- ORIVE G., Hernández R. M., Gascón A. R., Pedraz J. L., Micro and Nano Drug Delivery Systems in Cancer Therapy, Cancer Therapy, 3, 131-138, (2005).
- PEPPAS B. L., Blanchette J. O., Nanoparticle and Targeted Systems for Cancer Therapy, 56, 1649-1659, (2004).
- PILLIAI O., Dhanikula A. B., Phanchangula R., Drug Delivery: an Odyssey of 100 Years, Current Opinion in Chemical Biology, 5, 439-446, (2001).
- SHIKANOV A., Vaisman B., Krasko M.Y., Nyska A., Domb A.J., Poly(sebacic acid-coricinoleic acid) Biodegradable Carrier for Paclitaxel: In Vitro Release and In Vivo Toxicity, Journal of Biomedical Materials Research, 69(1), 47-54, (2004).
- SINGH G., New chemotherapy delivery methods, International Biopharmaceutical Association Publication. <http://www.ibpassociation.org/IBPA articles/feb2006issue/New_Chemo_by_Gurdeep.doc> Son giriş tarihi: 10 Mayıs 2008, (2006).
- SLIVNIAK R., Ezra A., Domb A.J., Hydrolytic Degredation and Drug Release of Ricinoleic Acid-Lactic Acid Copolyesters, Pharmaceutical Research, 23(6), 1306-1312, (2006).
- SOKOLOSKY-PAPKOV M., Shikanov A., Kumar N., Vaisman B., Domb A.J., Fatty Acid Based Biodegradable Polymers-Synthesis and Applications, Bulletin of the Israel Chemical Society, 23,12-17, (2008).
- TAYADE P.L., Kale R.D., Encapsulation of Water Insoluble Drug by a Cross-Linking Technique: Effect of Process and Formulation Variables on Encapsulation Efficiency, Particle Size, and in vitro Dissolution Rate, AAPS PharmSci, 6(1), 1-8, (2004).
- TOMALIA D.A., Fréchet J. M. J., Discovery of Dendrimers and Dendritic Polymers: A Brief Historical Perspective, Journal of Polymer Science: Part A: Polymer Chemistry, 40, 2719–2728, (2002).
- TWYMAN L. J., King A. S. H., Burnett J., Martin I. K., Synthesis of Aromatic Hyperbranched PAMAM Polymers”, Tetrahedron Letters, 45, 433-435, (2004).
- ULBRICH K., Subr V., Polymeric Anti-Cancer Drugs With pH-Controlled Activation, Advanced Drug Delivery Reviews, 56, 1023-1050, (2004).
- VAULTHIER C., Dubernet C., Chauvierre C., Brigger I., Couvreur P., Drug Delivery to Resistant Tumors: The Potential of Poly(alkyl cyonoacrylate) Nanoparticles, Journal of Controlled Release, 93, 151-160, (2003).
- VISHNU Y.V., Chandrasekhar K., Ramesh G., Rao Y.M., Development of Mucoadhesive Patches for Buccal Administration of Carvedilol Current Drug Delivery, 4, 27-39, (2007).
- VOGLESON C. T., Advances in Drug Delivery Systems, Modern Drug Discovery, 5(4), 439-446, (2001).
- ZAGAR E., Zigon M., Characterization of a Commercial Hyperbranched Aliphatic Polyester Based on 2,2-Bis(methylol)propionic Acid, Macromolecules, 35, 9913-9925, (2002).
- ZHANG Z., Feng S.S., The Drug Encapsulation Efficiency, In Vitro Drug Release, Cellular Uptake and Cytotoxicity of Paclitaxel-Loaded Poly(lactide)–Tocopheryl Polyethylene Glycol Succinate Nanoparticles, Biomaterials, 27, 4025–4033, (2006).
- ZOU J., Shi W., Wang J., Bo J., Encapsulation and Controlled Release of a Hydrophobic Drug Using Novel Nanoparticle Forming Hyperbranched Polyester, Macromolecular Bioscience, 5, 662-668, (2005).
| APA | GÜNDÜZ U, GÜNDÜZ G, DARCANSOY İŞERİ Ö, KARS D (2009). Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. , 1 - 47. |
| Chicago | GÜNDÜZ Ufuk,GÜNDÜZ Güngör,DARCANSOY İŞERİ Özlem,KARS Demirel Meltem Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. (2009): 1 - 47. |
| MLA | GÜNDÜZ Ufuk,GÜNDÜZ Güngör,DARCANSOY İŞERİ Özlem,KARS Demirel Meltem Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. , 2009, ss.1 - 47. |
| AMA | GÜNDÜZ U,GÜNDÜZ G,DARCANSOY İŞERİ Ö,KARS D Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. . 2009; 1 - 47. |
| Vancouver | GÜNDÜZ U,GÜNDÜZ G,DARCANSOY İŞERİ Ö,KARS D Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. . 2009; 1 - 47. |
| IEEE | GÜNDÜZ U,GÜNDÜZ G,DARCANSOY İŞERİ Ö,KARS D "Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması." , ss.1 - 47, 2009. |
| ISNAD | GÜNDÜZ, Ufuk vd. "Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması". (2009), 1-47. |
| APA | GÜNDÜZ U, GÜNDÜZ G, DARCANSOY İŞERİ Ö, KARS D (2009). Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. , 1 - 47. |
| Chicago | GÜNDÜZ Ufuk,GÜNDÜZ Güngör,DARCANSOY İŞERİ Özlem,KARS Demirel Meltem Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. (2009): 1 - 47. |
| MLA | GÜNDÜZ Ufuk,GÜNDÜZ Güngör,DARCANSOY İŞERİ Özlem,KARS Demirel Meltem Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. , 2009, ss.1 - 47. |
| AMA | GÜNDÜZ U,GÜNDÜZ G,DARCANSOY İŞERİ Ö,KARS D Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. . 2009; 1 - 47. |
| Vancouver | GÜNDÜZ U,GÜNDÜZ G,DARCANSOY İŞERİ Ö,KARS D Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması. . 2009; 1 - 47. |
| IEEE | GÜNDÜZ U,GÜNDÜZ G,DARCANSOY İŞERİ Ö,KARS D "Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması." , ss.1 - 47, 2009. |
| ISNAD | GÜNDÜZ, Ufuk vd. "Anti-kanser ilaç salımına yönelik dendritik polimer sentezi ve hücre kültürlerinde uygulanması". (2009), 1-47. |
